Investors

Shareholders

The Company’s issued share capital, as at 12 February 2025, consists of 262,586,405 ordinary shares with a nominal value of US $0.000001 each (“Ordinary Shares”).

Please note that the Company has, through its Articles of Association, elected to be treated as a UK-issuing company. Accordingly, significant shareholdings are disclosed at 3%.

At 12 February 2025 the following interests of shareholders in excess of 3%, have been notified to the Company.

SHAREHOLDERNUMBER OF ORDINARY SHARES HELDORDINARY SHARES AS % OF ISSUED SHARE CAPITAL
Premier Investissement SAS73,478,56727.98%
Kapitalforeningen Wealth Invest34,447,65113.12%
The Bank of Nova Scotia12,280,0004.68%
Ory Weihs8,137,4443.10%

Directors Holdings

SHAREHOLDERNUMBER OF ORDINARY SHARES HELDORDINARY SHARES AS % OF ISSUED SHARE CAPITAL
Ory Weihs8,137,4443.10%
David King100,0000.04%
Marcus Rich88,4580.03%
Julie Markey63,0640.02%

Not In Public Hands

In accordance with the AIM Rule 26 in so far as the Company is aware, at 12 February 2025 the percentage of the Company’s issued share capital that is not in public hands is 31.93%.

SHAREHOLDERNUMBER OF ORDINARY SHARES HELDORDINARY SHARES AS % OF ISSUED SHARE CAPITAL
Premier Investissement SAS73,478,56727.98%
Ory Weihs8,137,4443.10%
Ocorian Trustees (Jersey) Limited*1,973,0760.75%
David King100,0000.04%
Marcus Rich88,4580.03%
Julie Markey63,0640.02%
Total83,840,60931.93%

* Ocorian Trustees (Jersey) Limited is the appointed trustee (the “Trustee “) for the purposes of the Company’s 2017 and 2020 Global Share Incentive Plans (together the “GSIP“). The shares will be used to satisfy future obligations of the Company under the GSIP. Under the terms of the trust agreement, the Trustee has agreed to all entitlements to dividends issued by the Company, in each case, in respect of such shares prior to the transfer of those shares to satisfy the exercise of options pursuant to the terms of the GSIP.